Handa Pharmaceuticals, Inc. (TPEX:6620)

Handa Pharmaceuticals Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 21, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	13,609	10,576	25,891	16,074	8,451	2,820
Market Cap Growth	29.20%	-59.15%	61.07%	90.20%	199.72%	-18.91%
Enterprise Value	11,044	8,085	23,747	15,869	8,249	2,326
Last Close Price	86.50	73.58	179.00	118.61	65.86	23.12
PE Ratio	19.09	22.37	35.62	-	-	-
PS Ratio	8.41	12.73	23.40	81.32	289.08	97.71
PB Ratio	3.03	3.39	9.39	22.29	18.25	5.23
P/TBV Ratio	3.67	4.89	9.52	23.46	19.80	5.59
P/FCF Ratio	77.48	21.59	38.79	-	-	-
P/OCF Ratio	70.05	21.25	38.74	-	-	-
EV/Sales Ratio	6.83	9.73	21.47	80.28	282.15	80.61
EV/EBITDA Ratio	11.12	19.20	34.00	-	-	-
EV/EBIT Ratio	12.73	19.34	34.25	-	-	-
EV/FCF Ratio	62.87	16.51	35.58	-	-	-
Debt / Equity Ratio	0.01	0.01	0.01	0.04	0.03	0.03
Debt / EBITDA Ratio	0.05	0.09	0.02	-	-	-
Debt / FCF Ratio	0.28	0.08	0.02	-	-	-
Asset Turnover	-	0.26	0.58	0.31	0.05	0.04
Quick Ratio	32.25	8.49	12.89	11.63	10.05	9.05
Current Ratio	32.44	8.72	12.96	13.07	10.57	10.79
Return on Equity (ROE)	-	16.10%	41.81%	-6.76%	-49.43%	-41.47%
Return on Assets (ROA)	-	8.07%	22.64%	-8.54%	-29.36%	-27.20%
Return on Invested Capital (ROIC)	41.24%	46.33%	151.89%	-30.57%	-118.36%	-143.32%
Return on Capital Employed (ROCE)	18.80%	13.10%	24.50%	-11.80%	-54.20%	-58.30%
Earnings Yield	5.02%	4.47%	2.81%	-0.25%	-2.93%	-10.00%
FCF Yield	1.29%	4.63%	2.58%	-1.32%	-2.19%	-11.20%
Dividend Yield	1.72%	2.04%	0.56%	-	-	-
Payout Ratio	34.59%	29.84%	-	-	-	-
Buyback Yield / Dilution	-6.72%	-4.73%	-7.29%	-6.65%	-1.87%	-5.35%
Total Shareholder Return	-5.00%	-2.69%	-6.73%	-6.65%	-1.87%	-5.35%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.